TAO Synergies Announces $11 Million Private Placement
Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG NEW YORK, Oct. 13, 2025 /PRNewswire/ — TAO Synergies Inc. (Nasdaq: TAOX) (the “Company”), a digital asset treasury company focused on Bittensor (TAO), the premier cryptotoken for decentralized artificial intelligence (DeAI), today announced that it has entered into a securities purchase […]
TETRA TECHNOLOGIES, INC. ANNOUNCES THIRD QUARTER 2025 EARNINGS RELEASE CONFERENCE CALL AND WEBCAST
THE WOODLANDS, Texas, Oct. 13, 2025 /PRNewswire/ — TETRA Technologies, Inc. (“TETRA” or the “Company”) (NYSE:TTI) announced today that it will release third quarter 2025 results after the closing of the market on Tuesday, October 28, 2025 and will host a conference call on Wednesday, October 29, 2025, at 10:30 a.m. Eastern Time to discuss the results. Brady M. […]
PUBM Investors Have Opportunity to Lead PubMatic, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PubMatic, Inc. (“PubMatic” or “the Company”) (NASDAQ: PUBM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]
KLC Investors Have Opportunity to Lead KinderCare Learning Companies, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against KinderCare Learning Companies, Inc. (“KinderCare” or “the Company”) (NYSE: KLC) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable to the Company’s Offering Documents issued […]
Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight
The allergic rhino-conjunctivitis market is experiencing steady growth, driven by the rising prevalence of allergic conditions and increased awareness of effective management options. Advances in treatment, including allergen immunotherapy and targeted biologics, are expanding therapeutic choices and improving patient outcomes. Additionally, the ongoing research and development of novel therapies, such as Immunotek’s MM09, MG01 + […]
Unicycive Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – UNCY
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (NASDAQ: UNCY ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders […]
Savara Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – SVRA
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. (“Savara ” or “the Company”) (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders […]
A. O. Smith Increases Quarterly Dividend to $0.36 per Share
MILWAUKEE, Oct. 13, 2025 /PRNewswire/ — On Monday, October 13, 2025, the board of directors of A. O. Smith Corporation (NYSE: AOS) approved a 6% increase in the company’s quarterly cash dividend rate to $0.36 per share. The dividend increase affects the company’s Common Stock and Class A Common Stock. The dividend is payable on […]
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]